Literature DB >> 17065979

Tobacco use among adults--United States, 2005.

.   

Abstract

Four of the Healthy People 2010 objectives regarding tobacco use are to reduce the prevalence of cigarette smoking to 12.0%, cigar smoking to 1.2%, use of smokeless tobacco to 0.4%, and to increase cessation attempts among adult smokers to 75.0%. To assess progress toward achieving these four objectives, CDC analyzed self-reported data from the 2005 National Health Interview Survey (NHIS). This report summarizes the results of these analyses, which indicated lagging progress on all four objectives. In 2005, approximately 20.9% of U.S. adults were current cigarette smokers, the same percentage as in 2004, suggesting that the 8-year decline in smoking prevalence among adults in the United States might be stalling. In addition, the findings indicated that, in 2005, an estimated 2.2% of U.S. adults were current cigar smokers, 2.3% used smokeless tobacco, and 42.5% of current cigarette smokers had stopped smoking for at least 1 day in the preceding 12 months because they were trying to quit. To meet the Healthy People objectives for 2010, full implementation of effective, comprehensive tobacco-control programs that address both initiation and cessation of tobacco use is needed in all states and U.S. territories.

Entities:  

Mesh:

Year:  2006        PMID: 17065979

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  140 in total

1.  Partner smoking characteristics: Associations with smoking and quitting among blue-collar apprentices.

Authors:  Cassandra A Okechukwu; Kim Nguyen; Norval J Hickman
Journal:  Am J Ind Med       Date:  2010-11       Impact factor: 2.214

2.  Life course socioeconomic conditions, passive tobacco exposures and cigarette smoking in a multiethnic birth cohort of U.S. women.

Authors:  Parisa Tehranifar; Yuyan Liao; Jennifer S Ferris; Mary Beth Terry
Journal:  Cancer Causes Control       Date:  2009-02-24       Impact factor: 2.506

Review 3.  Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association.

Authors:  Carlos J Rodriguez; Matthew Allison; Martha L Daviglus; Carmen R Isasi; Colleen Keller; Enrique C Leira; Latha Palaniappan; Ileana L Piña; Sarah M Ramirez; Beatriz Rodriguez; Mario Sims
Journal:  Circulation       Date:  2014-07-14       Impact factor: 29.690

Review 4.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  Chinese physicians and their smoking knowledge, attitudes, and practices.

Authors:  Yuan Jiang; Michael K Ong; Elisa K Tong; Yan Yang; Yi Nan; Quan Gan; Teh-Wei Hu
Journal:  Am J Prev Med       Date:  2007-07       Impact factor: 5.043

Review 6.  Tobacco use and cessation for cancer survivors: an overview for clinicians.

Authors:  Maher Karam-Hage; Paul M Cinciripini; Ellen R Gritz
Journal:  CA Cancer J Clin       Date:  2014-05-09       Impact factor: 508.702

7.  Impulsivity and cigarette smoking: discounting of monetary and consumable outcomes in current and non-smokers.

Authors:  Jonathan E Friedel; William B DeHart; Gregory J Madden; Amy L Odum
Journal:  Psychopharmacology (Berl)       Date:  2014-05-13       Impact factor: 4.530

8.  Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer.

Authors:  Christopher G Slatore; Alyson J Littman; David H Au; Jessie A Satia; Emily White
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

9.  Effects of acute tobacco abstinence in adolescent smokers compared with nonsmokers.

Authors:  Anne E Smith; Dana A Cavallo; Tricia Dahl; Ran Wu; Tony P George; Suchitra Krishnan-Sarin
Journal:  J Adolesc Health       Date:  2008-03-06       Impact factor: 5.012

10.  Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity.

Authors:  Roman Kotov; Lin T Guey; Evelyn J Bromet; Joseph E Schwartz
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.